Investigators
Psychiatrists and neurologists running trials on compounds tracked in the CNS Pulse pipeline, ranked by recruiting and total trial activity.15 investigators linked to a tracked compound.
| Investigator | Affiliation | Recruiting | Trials |
|---|---|---|---|
| Carlos A Zarate, M.D. | National Institute of Mental Health (NIMH) | 4 | 12 |
| David Walling, Ph.D. | Collaborative Neuroscience Research - Garden Grove | 2 | 2 |
| Samuel McLean, MD | University of North Carollina at Chapel Hill | 2 | 2 |
| Mark Pollack, M.D. | Massachusetts General Hospital | 1 | 3 |
| Aaron Koenig, MD | Syndeio Biosciences | 1 | 2 |
| Rebecca B Price, PhD | University of Pittsburgh | 1 | 2 |
| Maurizio Fava, MD | Massachusetts General Hospital | 0 | 18 |
| Marco Pappagallo, MD | Icahn School of Medicine at Mount Sinai | 0 | 5 |
| Craig Surman, MD | Massachusetts General Hospital | 0 | 4 |
| Philip Scheltens, MD | Alheimer Research Center, VU medisch centrum | 0 | 4 |
| Hakop Gevorkyan, MD, MBA | California Clinical Trials Medical Group | 0 | 2 |
| Kevin Gray, MD | Addiction Sciences Division - Medical University of South Carolina | 0 | 2 |
| Larissa Mooney, MD | Department of Psychiatry and Biobehavioral Sciences - UCLA | 0 | 2 |
| Mark Leibowitz, MD | Collaborative Neuroscience Network | 0 | 2 |
| Matt Mandel, MD | BioXcel Therapeutics | 0 | 2 |